Medical and Pharmaceutical Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate For 63 per cent of patients, the cancer was either reduced or kept from worsening Joseph MortonDecember 3, 2024
Medical and Pharmaceutical Edgewise Therapetics shares skyrocket on positive clinical trial returns The company stock rose 55 per cent after results of one dose show immediate results Joseph MortonSeptember 19, 2024